StocksMedium•28 September 2026•
1 min read
BioNTech to Close Germany and Singapore Sites After Sale Fails
Key Facts
1BioNTech announced it will close manufacturing sites in Germany and Singapore after failing to find buyers.
2The closures are part of the company's pivot away from pandemic-era manufacturing levels.
BioNTech announced it will close manufacturing sites in Germany and Singapore after failing to find buyers for the facilities. Reuters reported that the closures are part of a restructuring process as the company scales back its pandemic-era footprint.
The decision marks a strategic pivot away from manufacturing levels established during the COVID-19 pandemic. The move indicates a contraction in the company's manufacturing base to align with current market demand.